Determining who foots the bill for America’s growing opioid epidemic may depend on how well the state of Oklahoma deploys a high-risk legal strategy this week against Johnson & Johnson and Teva Pharmaceutical Industries Ltd. At least 42 states and …
from News – Insurance Journal http://bit.ly/2VTR3sS
Visit us for News & Trend in Insurance Sector